• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加工历史对载体型干粉吸入剂中布地奈德表面界面性质的影响。

Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.

作者信息

Shur Jagdeep, Pitchayajittipong Chonladda, Rogueda Philippe, Price Robert

机构信息

Department of Pharmacy & Pharmacology, University of Bath, Bath, BA2 7AY, UK.

出版信息

Ther Deliv. 2013 Aug;4(8):925-37. doi: 10.4155/tde.13.69.

DOI:10.4155/tde.13.69
PMID:23919472
Abstract

Influence of air-jet micronization, post-micronization conditioning and storage on the surface properties of budesonide in dry-powder inhaler formulations was investigated. Crystalline budesonide was air jet-micronized and conditioned using organic vapor. Particle engineering was also used to fabricate respirable particles of budesonide. Surface imaging by atomic force microscopy suggested that micronized material possessed process-induced surface disorder, which relaxed upon conditioning with organic vapor. Particle engineered material was devoid of such surface disorder. Surface interfacial properties of all batches were different and correlated to in vitro fine particle delivery. The surface properties and in vitro performance of the conditioned material changed upon storage of the budesonide at 44% relative humidity and 25°C, while the micronized and particle-engineered material remained stable. These data suggest that processing conditions of budesonide affected the surface properties of the material, which was demonstrated to have direct affect on dry-powder inhaler formulation performance.

摘要

研究了气流微粉化、微粉化后处理及储存对布地奈德干粉吸入剂制剂表面性质的影响。将结晶布地奈德进行气流微粉化,并使用有机蒸汽进行后处理。还采用颗粒工程技术制备了可吸入的布地奈德颗粒。原子力显微镜表面成像表明,微粉化材料具有过程诱导的表面无序,在用有机蒸汽处理后这种无序会缓解。颗粒工程材料没有这种表面无序。所有批次的表面界面性质不同,且与体外细颗粒递送相关。在44%相对湿度和25°C条件下储存布地奈德时,后处理材料的表面性质和体外性能发生了变化,而微粉化和颗粒工程材料保持稳定。这些数据表明,布地奈德的加工条件影响了材料的表面性质,这被证明对干粉吸入剂制剂性能有直接影响。

相似文献

1
Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.加工历史对载体型干粉吸入剂中布地奈德表面界面性质的影响。
Ther Deliv. 2013 Aug;4(8):925-37. doi: 10.4155/tde.13.69.
2
Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.主结晶条件对干粉吸入用微米化布地奈德的力学和界面性能的影响。
Int J Pharm. 2012 Jul 1;430(1-2):26-33. doi: 10.1016/j.ijpharm.2012.03.020. Epub 2012 Mar 17.
3
Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.用于改善丙酸氟替卡松干粉吸入器性能的表面改性乳糖颗粒的制备与评价
J Aerosol Med Pulm Drug Deliv. 2015 Aug;28(4):254-67. doi: 10.1089/jamp.2014.1146. Epub 2014 Dec 17.
4
Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.干粉吸入剂中的空气分级器技术(ACT) 第4部分。Novolizer多剂量干粉吸入器中空气分级器技术的性能。
Int J Pharm. 2006 Mar 9;310(1-2):81-9. doi: 10.1016/j.ijpharm.2005.11.029. Epub 2006 Jan 25.
5
SCF-engineered powders for delivery of budesonide from passive DPI devices.用于从被动式干粉吸入装置递送布地奈德的干细胞因子工程化粉末。
J Pharm Sci. 2005 Oct;94(10):2276-88. doi: 10.1002/jps.20305.
6
Evaluation of supercritical fluid engineered budesonide powder for respiratory delivery using nebulisers.评价使用雾化器进行呼吸输送的超临界流体工程化布地奈德粉末。
J Pharm Pharmacol. 2009 Dec;61(12):1625-30. doi: 10.1211/jpp/61.12.0006.
7
Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance.利用粉末流变学和渗透性预测干粉吸入器性能的能力和局限性。
Eur J Pharm Biopharm. 2012 Oct;82(2):417-23. doi: 10.1016/j.ejpb.2012.07.018. Epub 2012 Aug 9.
8
Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations.大乳糖载体颗粒的大小和表面粗糙度对干粉吸入剂配方的影响。
Int J Pharm. 2010 Dec 15;402(1-2):1-9. doi: 10.1016/j.ijpharm.2010.08.045. Epub 2010 Sep 15.
9
Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations.溴化异丙托品晶体形式对干粉吸入剂配方中微粉化和雾化行为的影响。
J Pharm Pharmacol. 2012 Sep;64(9):1326-36. doi: 10.1111/j.2042-7158.2012.01522.x. Epub 2012 May 14.
10
Extrinsic lactose fines improve dry powder inhaler formulation performance of a cohesive batch of budesonide via agglomerate formation and consequential co-deposition.外源性乳糖细粉通过团聚形成和随之而来的共沉积改善了布地奈德粘性批次干粉吸入剂的配方性能。
Int J Pharm. 2015 Jan 15;478(1):53-59. doi: 10.1016/j.ijpharm.2014.11.019. Epub 2014 Nov 13.

引用本文的文献

1
Controlled Pulmonary Delivery of Carrier-Free Budesonide Dry Powder by Atomic Layer Deposition.通过原子层沉积实现无载体布地奈德干粉的可控肺部递送。
ACS Nano. 2021 Apr 27;15(4):6684-6698. doi: 10.1021/acsnano.0c10040. Epub 2021 Mar 26.
2
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate.二次加工对丙酸氟替卡松结构弛豫动力学的影响。
AAPS PharmSciTech. 2015 Jun;16(3):589-600. doi: 10.1208/s12249-014-0222-8. Epub 2014 Nov 15.